Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asher Bio
Biotech
Asher drops 60% of staff to zero in on lead immunotherapy
Small immunotherapy biotech Asher Bio has reduced its workforce by 60%, sending 34 employees on their way and pivoting to a single immunotherapy.
Annalee Armstrong
Dec 19, 2023 3:25pm
Asher Bio snags $108M series B for three immunotherapy programs
Sep 1, 2021 7:00am
Synthekine snags $108M to drive two candidates into the clinic
Jun 10, 2021 8:00am
Asher Bio banks $55M to deliver more selective cytokines
Mar 23, 2021 7:00am
